Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Drinking alcohol 1-2 times a week may reduce urinary symptoms, but drinking more often might increase the risk.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

PRP improves hair growth in androgenic alopecia, especially when combined with minoxidil.

Biomembrane-based hydrogels can effectively promote chronic wound healing.

PrrH sRNA controls pyochelin production in *Pseudomonas aeruginosa*.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Cannabinoids may help treat various skin conditions.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Botulinum toxin is used in skin care for cosmetic and medical purposes.

β-catenin signaling speeds up hair follicle aging, causing graying and thinning.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Drug repositioning can save time and money but needs more support.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Many bodybuilders in Sergipe, Brazil use anabolic steroids, facing health risks like acne, irritability, and hypertension.

CBD may improve skin and hair health, but its effective use and safety need more research.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.